<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Biotechnology DSM 201 Unit 5 | 3rd Semester Notes - Knowlet</title>
    <meta name="description" content="Exam notes for Unit 5 of BTC DSM 201T Microbiology and Immunology: Antigen Presentation, Autoimmune Diseases, Immunodeficiency (HIV/AIDS), and Immunodiagnostics (ELISA/RIA).">
    <meta name="keywords" content="Biotechnology, Immunology, Antigen Recognition, MHC I, MHC II, Antigen Processing and Presentation, Autoimmune Diseases, Systemic Lupus Erythematosus, Rheumatoid Arthritis, Immunodeficiency, HIV, AIDS, Immunodiagnostics, ELISA, RIA">
    <link rel="stylesheet" href="../../../../assets/styles/units.css">
        
    <link rel="stylesheet" href="../../../../assets/styles/supabase.css">
    <style>
        body { font-family: 'Arial', sans-serif; line-height: 1.6; color: #333; margin: 0; padding: 20px; background-color: #f4f7f6; }
        .container { max-width: 1000px; margin: auto; background: #fff; padding: 25px; border-radius: 10px; box-shadow: 0 0 15px rgba(0, 0, 0, 0.1); }
        h1, h2, h3 { color: #004d40; border-bottom: 2px solid #e0f2f1; padding-bottom: 5px; margin-top: 20px; }
        h1 { font-size: 2em; border-bottom: 4px solid #004d40; }
        h2 { font-size: 1.6em; border-left: 5px solid #00897b; padding-left: 10px; }
        h3 { font-size: 1.3em; color: #00695c; border-bottom: 1px dashed #bdbdbd; padding-left: 10px; }
        ul, ol { margin: 15px 0; padding-left: 30px; }
        li { margin-bottom: 10px; }
        strong { color: #d84315; }
        em { color: #1e88e5; }
        table { width: 100%; border-collapse: collapse; margin: 20px 0; }
        th, td { border: 1px solid #ddd; padding: 12px; text-align: left; }
        th { background-color: #00897b; color: white; }
        tr:nth-child(even) { background-color: #f2f2f2; }
        blockquote { border-left: 5px solid #ffb300; background-color: #fff9c4; padding: 15px; margin: 20px 0; font-style: italic; }
        .exam-tip { border: 2px solid #e53935; padding: 15px; margin: 20px 0; background-color: #ffcdd2; border-radius: 5px; }
        .application { border-left: 5px solid #43a047; background-color: #e8f5e9; padding: 10px; margin: 15px 0; }
        a { color: #00695c; text-decoration: none; }
        a:hover { text-decoration: underline; }
    </style>

  <script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-5362217555997798"
    crossorigin="anonymous"></script>
</head>

<body>
    <div class="container">
        <h1>UNIT 5: Antigen Recognition and Presentation, Autoimmune Diseases, Immunodeficiency, and Immunodiagnostics</h1>
        <p class="exam-tip"><strong>Exam Focus:</strong> The comparison table for **MHC Class I vs. Class II** is essential (which T cell interacts, which cells express it, source of antigen). Be prepared to describe the basic principles of **ELISA** and **RIA** and list examples of autoimmune diseases.</p>
        
        <h2>Table of Contents</h2>
        <ol>
            <li><a href="#antigen-recognition">Antigen Recognition and Processing </a>
                <ul>
                    <li><a href="#mhc">Class I & Class II MHC Molecules</a></li>
                    <li><a href="#presentation">Antigen Processing and Presentation by MHC Molecule</a></li>
                </ul>
            </li>
            <li><a href="#autoimmune">Autoimmune Diseases </a>
                <ul>
                    <li><a href="#organ-specific">Organ-specific Autoimmune Diseases</a></li>
                    <li><a href="#systemic">Systemic Autoimmune Diseases</a></li>
                </ul>
            </li>
            <li><a href="#immunodeficiency">Immunodeficiency: HIV and AIDS </a></li>
            <li><a href="#immunodiagnostics">Introduction to Immunodiagnostics </a>
                <ul>
                    <li><a href="#elisa">ELISA</a></li>
                    <li><a href="#ria">RIA</a></li>
                </ul>
            </li>
        </ol>

        <h2 id="antigen-recognition">1. Antigen Recognition and Processing </h2>
        <p>T cells cannot directly recognize soluble antigens. They require antigens to be processed and presented on the surface of other cells by Major Histocompatibility Complex (MHC) molecules. </p>
        
        <h3 id="mhc">Class I & Class II MHC Molecules </h3>
        <table style="font-size: 0.9em;">
            <thead>
                <tr>
                    <th>Feature</th>
                    <th>MHC Class I (HLA-A, B, C)</th>
                    <th>MHC Class II (HLA-DP, DQ, DR)</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>**Expression**</td>
                    <td>Expressed on **all nucleated cells**.</td>
                    <td>Expressed primarily on **Antigen Presenting Cells (APCs)** (Dendritic cells, Macrophages, B cells).</td>
                </tr>
                <tr>
                    <td>**Source of Antigen**</td>
                    <td>Endogenous (intracellular, e.g., viral proteins, cancer proteins).</td>
                    <td>Exogenous (extracellular, e.g., bacteria, toxins).</td>
                </tr>
                <tr>
                    <td>**T cell Interaction**</td>
                    <td>Interacts with **Cytotoxic T cells (T<sub>C</sub>)** via CD8 coreceptor.</td>
                    <td>Interacts with **Helper T cells (T<sub>H</sub>)** via CD4 coreceptor.</td>
                </tr>
            </tbody>
        </table>
        
        <h3 id="presentation">Antigen Processing and Presentation by MHC Molecule </h3>
        <p>The pathway by which antigens are degraded into peptides and complexed with MHC molecules. </p>
        <ul>
            <li>**MHC Class I Pathway:** Antigen (e.g., viral protein) is produced in the cytoplasm, degraded by the **proteasome**, transported into the ER, loaded onto nascent MHC-I molecules, and presented on the cell surface. </li>
            <li>**MHC Class II Pathway:** Antigen (e.g., bacteria) is taken up by the APC via endocytosis, degraded in endosomes/lysosomes, loaded onto MHC-II molecules in a specialized vesicle, and presented on the cell surface. </li>
        </ul>
        

        <h2 id="autoimmune">2. Autoimmune Diseases </h2>
        <p>These diseases result from the failure of the immune system to distinguish between self and non-self, leading to an immune response that targets and damages the body's own tissues (loss of **self-tolerance**). </p>
        
        <h3 id="organ-specific">Organ-specific Autoimmune Diseases </h3>
        <p>The immune response is primarily directed against antigens restricted to a single organ. </p>
        <ul>
            <li>**Hashimoto's Disease:** Targets the **thyroid gland** cells, leading to hypothyroidism (underactive thyroid). </li>
            <li>**Myasthenia Gravis:** Targets acetylcholine receptors at the neuromuscular junction, leading to muscle weakness. </li>
        </ul>
        
        <h3 id="systemic">Systemic Autoimmune Diseases </h3>
        <p>The immune response is directed against antigens that are broadly distributed throughout the body. </p>
        <ul>
            <li>**Systemic Lupus Erythematosus (SLE):** Produces autoantibodies against common cellular components (e.g., DNA, nuclear proteins), causing inflammation and damage to multiple organs (skin, joints, kidneys). </li>
            <li>**Rheumatoid Arthritis (RA):** Targets the lining of the joints (synovium), causing chronic inflammation, pain, and joint deformation. </li>
        </ul>

        <h2 id="immunodeficiency">3. Immunodeficiency: HIV and AIDS </h2>
        <p>A state where the immune system's ability to fight infectious diseases and cancer is compromised.</p>
        <ul>
            <li>**HIV (Human Immunodeficiency Virus):** A retrovirus that primarily targets and destroys CD4<sup>+</sup> **Helper T cells**, which are crucial coordinators of the adaptive immune response. </li>
            <li>**AIDS (Acquired Immunodeficiency Syndrome):** The final stage of HIV infection, characterized by a severely depleted CD4<sup>+</sup> T cell count and the onset of opportunistic infections and unusual cancers.  The destruction of CD4<sup>+</sup> cells causes a catastrophic collapse of both humoral and cell-mediated immunity. </li>
        </ul>

        <h2 id="immunodiagnostics">4. Introduction to Immunodiagnostics </h2>
        <p>Techniques utilizing the highly specific nature of antigen-antibody binding to detect and measure antigens (pathogens, hormones) or antibodies (indicative of infection or immunity) in a sample. </p>
        
        <h3 id="elisa">ELISA (Enzyme-Linked Immunosorbent Assay) </h3>
        <p>A plate-based assay technique designed for detecting and quantifying peptides, proteins, antibodies, and hormones. </p>
        <ul>
            <li>**Principle:** Uses an enzyme (linked to an antibody) that produces a color change when a substrate is added, indicating the presence of the target molecule. </li>
            <li>**Types:** Direct, Indirect, Sandwich, and Competitive.</li>
        </ul>
        
        <h3 id="ria">RIA (Radioimmunoassay) </h3>
        <p>A highly sensitive technique used to measure concentrations of substances, usually antigens or antibodies, by employing **radioactive isotopes** (tracers). </p>
        <ul>
            <li>**Principle:** Involves the competitive binding of a known amount of radioactively labeled antigen with the unknown, unlabeled antigen in the sample to a limited amount of antibody. The amount of radioactivity measured is inversely proportional to the amount of unlabeled antigen in the sample. </li>
        </ul>
    </div>
    <div id="app"></div>
        
    <script src="../../../../assets/scripts/units.js"></script>
        
    <script src="https://cdn.jsdelivr.net/npm/@supabase/supabase-js@2"></script>
        
    <script src="../../../../assets/scripts/supabase.js"></script>
        
</body>
</html>